Leap Investments’s Precigen PGEN Stock Holding History

Leap Investments’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$123K	Sell	24,700 -1,100	-4%	-$3.74K	0.08%	343
2020 Q1	$88K	Buy	+25,800	New	+$111K	0.13%	279
2019 Q4	–	Sell	-10,900	Closed	-$62K	–	541
2019 Q3	$62K	Buy	+10,900	New	+$74.1K	0.03%	384

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Leap Investments's PGEN Position: Q2 2020 in Review

Leap Investments reduced its Precigen (PGEN) stake by 4.3% in Q2 2020, selling an estimated $3.74K and leaving 24,700 shares worth $123K. The position accounts for 0.08% of the portfolio, ranked #343.

Leap Investments first reported a position in PGEN in Q3 2019 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold PGEN as of Q2 2020.

Leap Investments held 24,700 shares of Precigen worth $123K as of Q2 2020.
Leap Investments sold 1,100 Precigen shares in Q2 2020, an estimated $3.74K.
Precigen made up 0.08% of Leap Investments's portfolio in Q2 2020, its #343 holding.
Leap Investments first reported a position in Precigen in Q3 2019 and has held it in 3 quarters since.
154 funds tracked by Wall St. Rank held Precigen as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.